NCT03476343 is a NA clinical trial of GE OPTIMA MR430s with HDx/GE Electronics in NICU MRI, sponsored by Children's Hospital Medical Center, Cincinnati.

Who is sponsoring NCT03476343?

NCT03476343 is sponsored by Children's Hospital Medical Center, Cincinnati.

What drugs are being tested in NCT03476343?

Interventions in NCT03476343: GE OPTIMA MR430s with HDx/GE Electronics.

Is NCT03476343 still recruiting?

NCT03476343 is currently completed. Last updated 12 February 2025.

Are results published for NCT03476343?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-02-12 · How we verify

NCT03476343

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Use of a Neonatal MRI System

Completed NA Results posted Last updated 12 February 2025

What this trial tests

NA trial testing GE OPTIMA MR430s with HDx/GE Electronics in NICU MRI in 386 participants. Completed in 9 September 2022.

Timeline

11 February 2018

Primary endpoint
3 June 2022

9 September 2022

Quick facts

Lead sponsor	Children's Hospital Medical Center, Cincinnati
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	386
Start date	11 February 2018
Primary completion	3 June 2022
Estimated completion	9 September 2022
Sites	1 location across United States

Drugs / interventions tested

GE OPTIMA MR430s with HDx/GE Electronics

Conditions studied

NICU MRI — all drugs for NICU MRI →

Sponsor

Children's Hospital Medical Center, Cincinnati

Who can join

Eligibility, any sex, with NICU MRI. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants With Adverse Events as Observed During and After Scanning. Primary · Day 1

Any observed physical changes will be recorded during and after scanning

Group	Value	95% CI
MRI for Neonates	0

Each Infant's Baseline Measurement for Weight Will be Recorded. Secondary · Day 1

These measures will be used in order to facilitate future design of coils and transport tables for the customized MRI system.

Group	Value	95% CI
MRI for Neonates	2.92	0.54 – 4.89

Each Infant's Anatomy Scanned Will be Obtained. Secondary · Day 1

The anatomy used will be used in order to facilitate understand the need for specific coils for the customized MRI system.

Group	Value	95% CI
MRI for Neonates	357
MRI for Neonates	1
MRI for Neonates	2
MRI for Neonates	13

Baseline Measurement for Days Old Will be Recorded. Secondary · Day 1

These measures will be used in conjunction with the weight at the time of scan to facilitate future design of coils and transport tables for the customized MRI system.

Group	Value	95% CI
MRI for Neonates	20	1 – 155

Sponsor's own description

The purpose of the present study is to continue clinical scanning on the NICU MRI with improved administrative processes and procedures, thereby making medically indicated, state of the art/high end MRI exams available to all infants treated at CCHMC.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Children's Hospital Medical Center, Cincinnati trials

Trials by the same sponsor.

NCT07430332 — GLP-1 RA for Stage 1 Type 1 Diabetes · Phase 2 · not yet recruiting
NCT07077213 — 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients · recruiting
NCT07265141 — An Automated Virtual Reality Intervention to Enhance Firearm Safety Counseling in Pediatrics · NA · not yet recruiting
NCT07217444 — Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation · NA · recruiting
NCT07195123 — Evaluation of the SMART IBD App in Pediatric IBD · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03476343 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati
Last refreshed: 12 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03476343.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing